Healthcare plans

In the first 10 days of July, at least ten drugmakers and biotechnology companies have raised prices on at least 20 brand-name medicines.

Drug dependence can be an unintended consequence of a workplace injury, creating a crisis for the worker and their family.

In an effort to bring insurance carriers back to ACA exchanges, the U.S. government is increasing funding to insurers, which could spur brokers to recommend the exchanges to clients.

As the new head of Amazon, Berkshire and JPMorgan’s healthcare venture gets down to work, we can see what his plans might be for the future of large employer health plans.

The move by CMS may affect publicly traded insurers that have stuck with the ACA.

Drug dependence can be an unintended consequence of a workplace injury, creating a crisis for the worker and their family.

From healthcare costs and time and attendance, stress can have a big impact on workers. But employers in these states have a big advantage.

Benefit brokers who are proactive and address near-certain cost hikes will become valuable client counselors.

Employers have an opportunity to help employees make better decisions about retirement savings to address out-of-control medical costs.

The DOL upended the traditional dynamic of company-sponsored benefits and threw a lifeline to millions of small companies and their HR teams.

A “Hail Mary” pass is understandable when it comes to treating a seriously ill loved one, but questions remain about reimbursement.

The transaction sets up a showdown between Amazon and pharmacy benefit managers including Express Scripts, which recently agreed to be acquired by health insurer Cigna and CVS Health.

Employers have an opportunity to help employees make better decisions about retirement savings to address out-of-control medical costs.

The DOL upended the traditional dynamic of company-sponsored benefits and threw a lifeline to millions of small companies and their HR teams.

Attempting to circumvent the costly specialty drug chain, brokers are encouraging clients to shop for FDA-approved drugs outside the U.S.

The health venture established will take aim at intermediaries in the healthcare system as a part of a broad effort to reduce wasteful spending

The Cognoa solution advises parents of a possible developmental delays during a child's early years, recommend therapies.

The world’s biggest pharmaceutical companies, looking to sell a new type of cancer drug that could transform treatment, are grappling with an unusual challenge: finding patients.

The CEO of the Amazon-JPMC-Berkshire Hathaway aims to address the “tapeworm” eating the U.S. economy.